PHYSICOCHEMICAL STABILITY OF CRYSTALLINE SUGARS AND THEIR SPRAY-DRIEDFORMS - DEPENDENCE UPON RELATIVE-HUMIDITY AND SUITABILITY FOR USE IN POWDER INHALERS
V. Naini et al., PHYSICOCHEMICAL STABILITY OF CRYSTALLINE SUGARS AND THEIR SPRAY-DRIEDFORMS - DEPENDENCE UPON RELATIVE-HUMIDITY AND SUITABILITY FOR USE IN POWDER INHALERS, Drug development and industrial pharmacy, 24(10), 1998, pp. 895-909
Lactose, trehalose, sucrose, and mannitol were purchased in crystallin
e form and fractionated by sieving. Coarse (125-212 mu m) and fine (44
-74 mu m) free-flowing fractions were selected as typical of drug carr
iers in dry-powder inhalers. In addition, one batch of each sugar was
spray-dried to form a respirable powder (> 50% [w/w] < 5 mu m). Both f
ractions and the spray-dried powders were characterized before and aft
er storage for 30 days at < 23%, 23%, 52%, 75% and 93% relative humidi
ty (RH) at 25 degrees C. Moisture uptake was determined by thermogravi
metric analysis (TGA) validated by Karl Fischer titration. Sieve fract
ions (before storage at different RHs) and spray-dried materials (befo
re and after storage) were further characterized by differential scann
ing calorimetry (DSC) and x-ray powder diffraction (XRPD). All crystal
line sieve fractions (except sucrose at 93% RH) were stable at 25 degr
ees C and showed insignificant moisture uptake when exposed to each re
lative humidity for 30 days. Sucrose dissolved in sorbed moisture at 9
3% RH. Spray-dried lactose, sucrose, and trehalose, which were collect
ed in the amorphous form, showed moisture uptake, without recrystalliz
ation, when held for 30 days at 23% RH. These sugars recrystallized as
sintered masses and became undispersible at greater than or equal to
52% RH. Spray-dried mannitol was apparently 100% crystalline when coll
ected directly from the spray-dryer; it did not show humidity-induced
changes. The physicochemical behavior of each sugar form is discussed
as it relates to the sugar's suitability as a powder-inhaler excipient
, with both conventional and protein drugs.